Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cell Immunol. 2010 Oct 16;266(2):187–191. doi: 10.1016/j.cellimm.2010.10.003

Fig. 2. MN antigen presentation.

Fig. 2

Purified MN (5×104/well) from healthy controls and HCV-infected individuals were incubated with soluble HEL (A) or peptide (B) and T cell hybridoma (1×105/well) for 22 hrs. IL-2 levels were determined by ELISA.